iSpecimen Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 2.95 million compared to USD 2.52 million a year ago. Net loss was USD 2.43 million compared to USD 2.38 million a year ago.

Basic loss per share from continuing operations was USD 0.27 compared to USD 0.27 a year ago.